Trust Point’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Trust Point's MRNA Position: Q3 2026 in Review
Trust Point opened a new position in Moderna (MRNA) in Q3 2026: 1,500 shares worth $289K. The stake represents 0.02% of the portfolio and ranks #380 among its holdings. This is a return to the name: Trust Point previously reported a position in MRNA as recently as Q2 2024.
Trust Point first reported a position in MRNA in Q2 2024 and has held it in 2 quarters since. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Trust Point held 1,500 shares of Moderna worth $289K as of Q3 2026.
- Moderna was a new Trust Point position in Q3 2026.
- Moderna made up 0.02% of Trust Point's portfolio in Q3 2026, its #380 holding.
- Trust Point first reported a position in Moderna in Q2 2024 and has held it in 2 quarters since.
- 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.